Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$5.9 - $8.02 $85,148 - $115,744
14,432 New
14,432 $94,000
Q2 2022

Jul 27, 2022

SELL
$13.31 - $34.88 $98,667 - $258,565
-7,413 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$20.26 - $32.36 $16,876 - $26,955
833 Added 12.66%
7,413 $222,000
Q4 2021

Feb 14, 2022

BUY
$26.0 - $37.03 $171,080 - $243,657
6,580 New
6,580 $202,000

Others Institutions Holding RLAY

About Relay Therapeutics, Inc.


  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $583M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Vontobel Holding Ltd. Portfolio

Follow Vontobel Holding Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Vontobel Holding Ltd. with notifications on news.